Bucladesine: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
Line 23: Line 23:
| routes_of_administration =  
| routes_of_administration =  
}}
}}
__NOTOC__
{{SI}}
{{CMG}}
{{CMG}}


==Overview==
==Overview==
Line 38: Line 39:
[[Category:Phosphodiesterase inhibitors]]
[[Category:Phosphodiesterase inhibitors]]
[[Category:Cardiovascular Drugs]]
[[Category:Cardiovascular Drugs]]
[[Category:Drugs]]
[[Category:Drug]]
 
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}

Latest revision as of 20:35, 24 July 2014

Bucladesine
Clinical data
ATC code
Identifiers
CAS Number
PubChem CID
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC18H23N5NaO8P
Molar mass491.368 g/mol

WikiDoc Resources for Bucladesine

Articles

Most recent articles on Bucladesine

Most cited articles on Bucladesine

Review articles on Bucladesine

Articles on Bucladesine in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Bucladesine

Images of Bucladesine

Photos of Bucladesine

Podcasts & MP3s on Bucladesine

Videos on Bucladesine

Evidence Based Medicine

Cochrane Collaboration on Bucladesine

Bandolier on Bucladesine

TRIP on Bucladesine

Clinical Trials

Ongoing Trials on Bucladesine at Clinical Trials.gov

Trial results on Bucladesine

Clinical Trials on Bucladesine at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Bucladesine

NICE Guidance on Bucladesine

NHS PRODIGY Guidance

FDA on Bucladesine

CDC on Bucladesine

Books

Books on Bucladesine

News

Bucladesine in the news

Be alerted to news on Bucladesine

News trends on Bucladesine

Commentary

Blogs on Bucladesine

Definitions

Definitions of Bucladesine

Patient Resources / Community

Patient resources on Bucladesine

Discussion groups on Bucladesine

Patient Handouts on Bucladesine

Directions to Hospitals Treating Bucladesine

Risk calculators and risk factors for Bucladesine

Healthcare Provider Resources

Symptoms of Bucladesine

Causes & Risk Factors for Bucladesine

Diagnostic studies for Bucladesine

Treatment of Bucladesine

Continuing Medical Education (CME)

CME Programs on Bucladesine

International

Bucladesine en Espanol

Bucladesine en Francais

Business

Bucladesine in the Marketplace

Patents on Bucladesine

Experimental / Informatics

List of terms related to Bucladesine

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Bucladesine is a cyclic nucleotide derivative which mimics the action of endogenous cAMP and is a phosphodiesterase inhibitor.

Bucladesine is a cell permeable cAMP analog. The compound is used in a wide variety of research applications because it mimics cAMP and can induce normal physiological responses when added to cells in experimental conditions. cAMP is only able to elicit minimal responses in these situations.

The neurite outgrowth instigated by bucladesine in cell cultures has been shown to be enhanced by nardosinone.

Template:Phosphodiesterase inhibitors Template:Cardiac stimulants excluding cardiac glycosides